Evidence map›Paper›PMID 42352893›Full record

ReviewInternational journal of molecular sciences2026

Impact of Air Pollution on Metabolic Dysfunction-Associated Fatty Liver Disease.

Duoduo Lv, Heyu Tang, Lingyun Zhou

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Duoduo LvCenter of Infectious Diseases, West China Hospital of Sichuan University, No. 37 GuoXue Alley, Chengdu 610041, China.ORCID 0009-0007-1190-6667
Heyu TangDivision of Cellular and Molecular Therapy, Department of Pediatrics, University of Florida, Gainesville, FL 32611, USA.ORCID 0009-0002-7341-2121
Lingyun ZhouCenter of Infectious Diseases, West China Hospital of Sichuan University, No. 37 GuoXue Alley, Chengdu 610041, China.ORCID 0000-0002-6756-6725

Funding

National Natural Science Foundation of China 81802468
6 · The paper itself

Abstract

Metabolic dysfunction-associated fatty liver disease (MAFLD) is now recognized as a leading form of chronic liver disease globally and is strongly associated with metabolic abnormalities. Traditionally, the pathogenesis of MAFLD has mainly been attributed to genetic susceptibility and unhealthy lifestyles (such as high-calorie diets and sedentary behavior). However, in recent years, environmental factors, especially air pollution, have been confirmed as independent risk factors and important promoting factors for MAFLD development and further disease progression. This review summarizes current epidemiological findings on the link between air pollution exposure and MAFLD, while exploring its potential biological mechanisms involving systemic inflammation, oxidative stress, immune alteration, genetic risk, and epigenetic regulation underlying the relationship between air pollution and hepatic steatosis. It also reviews the additive interaction between air pollution and lifestyle or socioeconomic factors in MAFLD. Finally, we also discuss multilevel strategies spanning individual-, community-, national-, and global-level cooperation to address the increasing public health burden caused by air pollution. Therefore, incorporating the assessment and control of air pollution into the comprehensive strategies for MAFLD prevention and treatment has important scientific value and public health significance.

Indexed as

Air PollutionFatty LiverMetabolic DiseasesNon-alcoholic Fatty Liver DiseaseAir PollutantsAnimalsEnvironmental ExposureEpigenesis, GeneticHumansInflammationOxidative StressParticulate MatterRisk FactorsAir PollutantsParticulate Matterair pollutioninflammationMAFLDoxidative stressparticulate matter

Identifiers

PMID42352893
PMCPMC13299571

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.